» Authors » J A Weisbach

J A Weisbach

Explore the profile of J A Weisbach including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 220
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weisbach J, Burke H
Trends Biotechnol . 1990 Feb; 8(2):31-5. PMID: 1366494
Although the discovery and transfer of technology from universities to industry has been taking place for many years, the surge of activity in areas related to biotechnology, over the past...
2.
Sitrin R, PFEIFFER F, Rosenbloom J, Cooper D, Schmidt S, Peterson D, et al.
J Antibiot (Tokyo) . 1980 Apr; 33(4):383-92. PMID: 7410207
An efficient synthesis of the key 3',4'-galacto epoxide intermediate 4 obtained from the known 5,6-O,O'-cyclohexylidene-N,N'-bis-(methoxycarbonyl)-4-O-[2,6-bis(methoxycarbony lamino)-alpha-D-glucopyranosyl]-2-deoxystreptamine (5) is described. Treatment of this epoxide with sodium azide, followed by reduction and...
3.
PITKIN D, Actor P, Weisbach J
J Pharm Sci . 1980 Mar; 69(3):354-6. PMID: 7381721
Saturated fatty acids containing 10--14 carbon atoms were more potent inhibitors of serum protein binding than those containing shorter or longer carbon chains. Introduction of unsaturation into chains containing 16...
4.
Grappel S, GUARINI J, Actor P, Weisbach J
J Antibiot (Tokyo) . 1980 Jan; 33(1):85-7. PMID: 7372555
No abstract available.
5.
Uri J, Actor P, Zajac I, PITKIN D, Phillips L, GUARINI J, et al.
J Antibiot (Tokyo) . 1979 Nov; 32(11):1161-7. PMID: 118958
Three cephalosporins with 7-(2-hydroxyiminophenylacetamido) side chains (SK&F 79433, 80000 and 80303), differing in their 3-substituents, exhibited similar broad-spectrum antibacterial activity in vitro against strains of Staphylococcus aureus, Streptococcus faecalis and...
6.
Uri J, Actor P, Weisbach J
Experientia . 1979 Aug; 35(8):1034-5. PMID: 38987
Using the pH (buffered) sensitivity discs for the agar-diffusion bioassay of aminoglycoside antibiotics, characteristic response curves were obtained. Since the nature of the activities observed are structure-related, this method can...
7.
Uri J, Actor P, Weisbach J
J Antibiot (Tokyo) . 1978 Dec; 31(12):1304-5. PMID: 104947
No abstract available.
8.
Uri J, Actor P, Weisbach J
J Antibiot (Tokyo) . 1978 Aug; 31(8):789-91. PMID: 308500
No abstract available.
9.
Uri J, Actor P, Phillips L, Weisbach J
J Antibiot (Tokyo) . 1978 Jun; 31(6):580-5. PMID: 681239
Cephalosporins are chemotherapeutic agents whose spectrum and use are limited to antibacterial activity. Therefore, it was of interest to find several new semisynthetic cephalosporins which possess in vitro antifungal activity...
10.
Actor P, Uri J, Zajac I, GUARINI J, Phillips L, PITKIN D, et al.
Antimicrob Agents Chemother . 1978 May; 13(5):784-90. PMID: 96734
SK&F 75073, a new parenteral cephalosporin, was found to have broad in vitro and in vivo antibacterial activity including isolates usually resistant to cephalothin and cefazolin. This activity included indole-positive...